GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Net Margin %

Iran Daru (XTEH:IRDR1) Net Margin % : 0.00% (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Iran Daru's Net Income for the six months ended in . 20 was IRR0.00 Mil. Iran Daru's Revenue for the six months ended in . 20 was IRR0.00 Mil. Therefore, Iran Daru's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Iran Daru's Net Margin % or its related term are showing as below:


XTEH:IRDR1's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.1
* Ranked among companies with meaningful Net Margin % only.

Iran Daru Net Margin % Historical Data

The historical data trend for Iran Daru's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Net Margin % Chart

Iran Daru Annual Data
Trend
Net Margin %

Iran Daru Semi-Annual Data
Net Margin %

Competitive Comparison of Iran Daru's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Iran Daru's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's Net Margin % distribution charts can be found below:

* The bar in red indicates where Iran Daru's Net Margin % falls into.



Iran Daru Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Iran Daru's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Iran Daru's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Iran Daru  (XTEH:IRDR1) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Iran Daru Net Margin % Related Terms

Thank you for viewing the detailed overview of Iran Daru's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Iran Daru (XTEH:IRDR1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines